acetylcysteine and davallialactone

acetylcysteine has been researched along with davallialactone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhattari, G; Hwang, PH; Jeon, JG; Lee, IK; Lee, NH; Lee, YH; Yi, HK; Yun, BS	1
Arunachalam, S; Hwang, PH; Kim, MS; Kim, SY; Lee, SH; Lee, YH; Yi, HK; Yun, BS	1

Other Studies

2 other study(ies) available for acetylcysteine and davallialactone

Article	Year
Reactive oxygen species removal activity of davallialactone reduces lipopolysaccharide-induced pulpal inflammation through inhibition of the extracellular signal-regulated kinase 1/2 and nuclear factor kappa b pathway. Journal of endodontics, 2011, Volume: 37, Issue:4 Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Cell Separation; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dental Pulp; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Free Radical Scavengers; Humans; Intercellular Adhesion Molecule-1; Lactones; Lipopolysaccharides; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Nitric Oxide Synthase Type II; Pulpitis; Reactive Oxygen Species; Superoxide Dismutase; Vascular Cell Adhesion Molecule-1	2011
Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo. Journal of natural medicines, 2012, Volume: 66, Issue:1 Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Blotting, Western; Cardiomyopathies; Caspase 3; Cell Line; Cell Survival; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; JNK Mitogen-Activated Protein Kinases; Lactones; Male; Mice; Mice, Inbred BALB C; Myocytes, Cardiac; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Superoxide Dismutase; Time Factors	2012

Article

Year

Reactive oxygen species removal activity of davallialactone reduces lipopolysaccharide-induced pulpal inflammation through inhibition of the extracellular signal-regulated kinase 1/2 and nuclear factor kappa b pathway.

Journal of endodontics, 2011, Volume: 37, Issue:4

Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Cell Separation; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dental Pulp; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Free Radical Scavengers; Humans; Intercellular Adhesion Molecule-1; Lactones; Lipopolysaccharides; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Nitric Oxide Synthase Type II; Pulpitis; Reactive Oxygen Species; Superoxide Dismutase; Vascular Cell Adhesion Molecule-1

2011

Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo.

Journal of natural medicines, 2012, Volume: 66, Issue:1

Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Blotting, Western; Cardiomyopathies; Caspase 3; Cell Line; Cell Survival; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; JNK Mitogen-Activated Protein Kinases; Lactones; Male; Mice; Mice, Inbred BALB C; Myocytes, Cardiac; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Reactive Oxygen Species; Superoxide Dismutase; Time Factors

2012